RNAi-based
technologies are ideal for pest control as they can
provide species specificity and spare nontarget organisms. However,
in some pests biological barriers prevent use of RNAi, and therefore
broad application. In this study we tested the ability of a synthetic
cationic polymer, poly-[N-(3-guanidinopropyl)methacrylamide]
(pGPMA), that mimics arginine-rich cell penetrating peptides to trigger
RNAi in an insensitive animal—Spodoptera frugiperda. Polymer–dsRNA interpolyelectrolyte complexes (IPECs) were
found to be efficiently taken up by cells, and to drive highly efficient
gene knockdown. These IPECs could also trigger target gene knockdown
and moderate larval mortality when fed to S. frugiperda larvae. This effect was sequence specific, which is consistent with
the low toxicity we found to be associated with this polymer. A method
for oral delivery of dsRNA is critical to development of RNAi-based
insecticides. Thus, this technology has the potential to make RNAi-based
pest control useful for targeting numerous species and facilitate
use of RNAi in pest management practices.
We describe the synthesis of pro-antimicrobial networks via degradable acetals (PANDAs) as a new paradigm for sequestration and triggered release of volatile, bioactive aldehydes. PANDAs derived from diallyl p-chlorobenzaldehyde acetal degrade and release p-chlorobenzaldehyde as an antibacterial and antifungal agent under mild conditions (pH 7.4/high humidity). We show that PANDAs enable facile access to materials with tunable release profiles, potent antimicrobial activity without triggering antimicrobial resistance, and minimal cytotoxicity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.